Managing Medical Information Effectively Facilitates the Quality and Time to Delivering the Final Product

Abstract

Pharmaceutical products that promise a so-called “blockbuster potential” require an increasingly coordinated medical information function at the local, continental, and global levels. A strong emphasis must be placed upon the provision and evaluation of medical information. To assist in the management of this information, a number of tools and databases are employed. These databases reveal an explosion in the published literature on a specific immunosuppressive drug that is an example of the concepts presented in this paper. This growth has paralleled the increased use of the drug and the demand for information on the product. Worldwide, database users are able to provide medical information, and produce overviews for safety, regulatory, and marketing purposes. This both facilitates the quality and reduces the time to get the final written product to the target groups.

The databases and networks described embrace a number of critical success factors through the phases of drug clinical development and marketing. More specifically, it is concluded that a continuum of creation, coordination, communication, cooperation, and competition enables the medical information function to be highly effective at the national, European, and global levels.